Distribution Intelligence Systems v. Orthopedic Designs North America: Orthopedic Patent Case Dismissed with Prejudice in 89 Days
What would you like to do next?
Choose your path based on your current needs:
📋 Case Summary
| Case Name | Distribution Intelligence Systems, LLC v. Orthopedic Designs North America, Inc. |
| Case Number | 8:24-cv-00262 |
| Court | Florida Middle District Court |
| Duration | Jan 26 – Apr 24, 2024 89 Days |
| Outcome | Dismissal with Prejudice |
| Patents at Issue | |
| Accused Products | Talon DistalFix Proximal Femoral Nail, Talon Screw |
Case Overview
The Parties
⚖️ Plaintiff
A patent assertion entity that initiated the infringement action, asserting rights over patented technologies relevant to orthopedic fixation systems.
🛡️ Defendant
A medical device company that designs and markets orthopedic implants and fixation systems, including products targeting hip fracture treatment.
Patents at Issue
Two U.S. patents formed the legal foundation of this dispute, both covering orthopedic fixation technology. These patents sit within the crowded and commercially significant field of orthopedic implant patent litigation.
- • U.S. Patent No. 9,402,664 B2 — Directed to orthopedic fixation technology relevant to proximal femoral nailing systems.
- • U.S. Patent No. 8,617,160 B2 — A related patent covering fixation methodology applicable to hip fracture treatment devices.
Developing a new orthopedic device?
Check if your product design or technology might infringe these or related patents before launch.
The Verdict & Legal Analysis
Outcome
The case concluded through a stipulated dismissal with prejudice pursuant to Federal Rule of Civil Procedure 41(a)(1)(A)(ii), filed jointly by both parties. No damages award was disclosed, and no injunctive relief was granted or denied on the merits. Each party bore its own costs and attorneys’ fees.
Key Legal Issues
The **89-day duration** is notably short for patent infringement litigation, where the national median time to trial typically exceeds two years. This compressed timeline strongly suggests that substantive settlement negotiations commenced shortly after service of process, potentially prompted by a defendant’s early evaluation of litigation cost, validity exposure, or design-around feasibility. The absence of fee-shifting under 35 U.S.C. § 285 implies neither party successfully argued the other’s conduct warranted sanctions.
Freedom to Operate (FTO) Analysis
This case highlights critical IP risks in medical device development. Choose your next step:
📋 Understand This Case’s Impact
Learn about the specific risks and implications from this litigation.
- View all related patents in this orthopedic technology space
- See which companies are most active in orthopedic device patents
- Understand claim construction patterns
🔍 Check My Product’s Risk
Run a comprehensive FTO analysis for your own technology or product.
- Input your product description or technical features
- AI identifies potentially blocking patents
- Get actionable risk assessment report
High Risk Area
Proximal femoral nail and fixation systems
Dense Patent Landscape
In orthopedic trauma devices
Early Resolution Potential
For well-prepared defendants
✅ Key Takeaways
Stipulated dismissal with prejudice under FRCP 41(a)(1)(A)(ii) extinguishes all asserted and assertable claims — a complete bar to re-litigation on these patents against this defendant.
Search related case law →No fee-shifting indicates neither party’s conduct crossed the “exceptional case” threshold under § 285.
Explore legal provisions →The 89-day resolution signals robust pre-trial settlement leverage, likely driven by early validity or non-infringement analysis.
Analyze litigation trends →Frequently Asked Questions
The case involved U.S. Patent Nos. 9,402,664 B2 and 8,617,160 B2, both covering orthopedic fixation technology applicable to hip fracture treatment systems.
The parties filed a joint stipulation of dismissal with prejudice under Federal Rule of Civil Procedure 41(a)(1)(A)(ii), with each side bearing its own costs and attorney fees. No merits ruling was issued.
The swift resolution reinforces the value of early defense mobilization in medical device patent cases and highlights the importance of pre-launch FTO analysis in the orthopedic implant space.
Ready to Strengthen Your Patent Strategy?
Join 18,000+ IP professionals using PatSnap Eureka to conduct prior art searches, draft patents, and analyse competitive landscapes with AI-powered precision.
References
- PACER Case Locator — Case No. 8:24-cv-00262, M.D. Fla.
- USPTO Patent Center — Search US9402664B2 and US8617160B2
- Federal Circuit Bar Association — Patent Litigation Statistics
- Cornell Legal Information Institute — 35 U.S.C. § 285
- PatSnap — IP Intelligence Solutions for Law Firms
This article is for informational purposes only and does not constitute legal advice. All case information is drawn from publicly available court records. For platform capabilities, visit PatSnap.